Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
Purpose. To evaluate the role of the activation of mTOR (phosphorylated mTOR, p-mTOR) and the expression SSTR2A and IGF-1R as prognostic factor in well-differentiated neuroendocrine tumors. Methods. A retrospective study was conducted on data from patients with diagnosis of neuroendocrine tumor orig...
Saved in:
Main Authors: | G. Lamberti, C. Ceccarelli, N. Brighi, I. Maggio, D. Santini, C. Mosconi, C. Ricci, G. Biasco, D. Campana |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/7872519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography
by: Walter Koch, et al.
Published: (2014-06-01) -
NOP2/Sun RNA Methyltransferase 4 Regulates the Mammalian Target of Rapamycin Signaling Pathway to Promote Hepatocellular Carcinoma Progression
by: Congren Wang, et al.
Published: (2025-01-01) -
The Hyperactivation of JAK-STAT Signaling Connects Inborn Errors of Immunity and Autoimmune Diseases
by: JIANG Yi, et al.
Published: (2024-10-01) -
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
by: Mario Orozco-Morales, et al.
Published: (2021-01-01) -
Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis
by: S. I. Mozgovoi, et al.
Published: (2020-01-01)